|
CapitalSource, Home Depot, Jacobs, NeurogesX, UBS
By MarketWatch
Last Update: 7:24 AM ET Nov 17, 2009
TEL AVIV (MarketWatch) -- Stocks expected to move significantly in trading on Tuesday include CapitalSource, Exxon Mobil, Home Depot, Jacobs, NeurogesX, Pacific Sunwear and UBS.
Assured Guaranty Ltd. AGO narrowed its third-quarter net loss to $35 million, or 22 cents a share, from $63.3 million, or 69 cents a share, in the year-earlier period. Operating earnings, which exclude net realized investment gains and losses and other items, came in at 44 cents a share, up from 28 cents, the bond insurer said.
Autoliv Inc., ALV the Stockholm auto-safety-systems specialist, said on Tuesday that it agreed to acquire certain North American air-bag, seat-belt and steering-wheel assets from Delphi. Terms weren't disclosed.
Boeing, BA the Chicago aerospace giant, said on Tuesday from the Dubai Air Show that it received orders from two Algerian airlines for its model 737-800 jets. Terms weren't disclosed. Air Algerie ordered seven of the planes, bringing its 737 fleet to 22. The carrier also operates three Boeing 767-300 planes. And Boeing said Tassili Airlines placed its first order for Boeing planes, signing a deal for four 737-800 jets. The carrier is a subsidiary of Algerian-government-owned Sonatrach Petroleum Corp., Boeing said.
CapitalSource Inc.: CSE Omega Healthcare Investors Inc. OHI agreed to buy entities owning 80 long-term-care facilities for around $565 million. Omega also received an option to purchase an additional 63 facilities for around $295 million. Omega said it would pay for the facilities with shares, cash and the assumption of debt. CapitalSource said it expects to receive net proceeds of $280 million in cash and $51 million of Omega stock. Separately CSE named Steven Museles and James Pieczynski co-CEOs. Founder and current CEO John Delaney assumes the new role of executive chairman.
CF Industries Holdings Inc., CF the Deerfield, Ill., holding company for a producer and distributor of nitrogen and phosphate fertilizer products, said that a truck driver was killed and another injured when anhydrous ammonia was released during loading operations at an ammonia terminal in Pine Bend, Minn. The released ammonia dissipated and posed no hazard to the community, CF said, adding that it is cooperating with local officials and investigating the matter.
Covidien COV fourth-quarter net income dropped to $56 million, or 11 cents a share, from $409 million, or 81 cents a share, a year ago. Adjusted earnings per share at the health-care-products firm totaled 72 cents. Analysts had been expecting 70 cents a share. Sales were flat at $2.7 billion, hit by unfavorable exchange-rate moves. The firm upped its fiscal 2010 sales guidance to reflect the recent weakening of the U.S. dollar, the acquisition of Aspect Medical Systems and FDA approvals of oral transmucosal fentanyl citrate and Pennsaid. It now expects sales growth of 6% to 9%.
Exxon Mobil XOM was upped to overweight from equal weight by Barclays Capital, which lifted its price target to $92 from $90. The broker expects organic production growth of more than 3% next year and an average growth rate of 2.6% between 2009 and 2013. Exxon also is attractively priced compared with broad market and other energy names.
Home Depot, HD the Atlanta home-improvement retailing giant, reported fiscal third-quarter earnings fell 8.9% on 8% lower sales. Comparable-store sales for the quarter were down 6.9%, reflecting a drop of 7.1% at the U.S. stores. "There is still a great deal of pressure in the housing and home-improvement markets, though there are some positive signs of stabilization," Chairman and Chief Executive Frank Blake said. Home Depot now expects earnings from continuing operations for the year of $1.50 a share, up 9.5% from a year earlier. The retailer expects adjusted earnings of $1.55, a 13% drop from a year earlier. Read the MarketWatch account of Home Depot's results.
Jacobs Engineering Group Inc. JEC fiscal fourth-quarter profit totaled $79.3 million, or 63 cents a share, compared with $114.4 million, or 92 cents a share, in the year-earlier period. Analysts had expected 65 cents a share, according to FactSet. Revenue for the quarter ended Oct. 2 was $2.55 billion compared to $3.20 billion. The Pasadena, Calif., company also set its initial forecast for 2010 earnings per share at a range of $2 to $2.60.
Microsoft Corp.: MSFT A Chinese court found that the company violated the intellectual property of local company Zhongyi Electronic Ltd., Dow Jones Newswires reported Tuesday. The court found Microsoft had exceeded the scope of an agreement to use and sell font types owned by Zhongyi and ordered the U.S. software giant and its China-based unit to stop selling products that use the fonts, the report said.
NeurogesX Inc. NGSX said late Monday its pain treatment, Qutenza, was approved by the U.S. Food and Drug Administration. The dermal patch uses a high-concentration dose of synthetic capsaicin to treat postherpetic neuralgia, or nerve pain that can follow an outbreak of shingles. The clearance by the FDA is the first for San Mateo, Calif., NeurogesX. The company said it plans to commercialize Qutenza in the U.S. through its own sales force and aims for launch in the first half of 2010.
Nortel Networks Corp. NRTLQ reported its third-quarter net loss attributable to the company narrowed to $1.02 a share from $6.85 in the year-earlier period. Revenue fell to $1.05 billion from $1.6 billion.
Novartis AG, NVS the Basel health-care giant, on Tuesday reported progress from clinical trials of its influenza A (H1N1) vaccine. In clinical trials, a single dose of the vaccine, which is half the currently approved U.S. dose, "fulfilled immune-response criteria associated with protection in adults and the elderly," those who are age 65 and older, the company said in a statement. The data "suggest that many more people could potentially be vaccinated with our current vaccines supply, protecting more people earlier against the current pandemic," said Andrin Oswald, chief executive of Novartis Vaccines & Diagnostics.
Pacific Sunwear of California Inc. PSUN reported its third-quarter net loss widened to $10.9 million, or 17 cents a share, from $2.5 million, or 4 cents a share, in the year-earlier period. Revenue totaled $268.3 million, down from $323.6 million. The clothing retailer expects a loss of about 28 cents to 35 cents a share for the fourth quarter.
Playboy Enterprises Inc. PLA Chief Financial Officer Linda Havard resigned, effective Dec. 31. The company will start to look for a successor immediately. The resignation comes amid media reports that the company is holding talks with a potential buyer.
Roche: RHHBY The Genentech subsidiary of the Basel health-care giant said on Tuesday that it submitted to the U.S. Food and Drug Administration two applications to market Avastin to treat women who have not received chemotherapy for advanced HER2-negative breast cancer.
Time Warner Inc. TWX said it will spin off AOL on Dec. 9. AOL common stock will begin trading on the New York Stock Exchange Dec. 10 under the symbol AOL. Time Warner holders of record as of Nov. 27 will receive one share of AOL stock for every 11 shares of the parent they own.
UBS UBS set medium-term targets for growth and profitability, including reaching annual pretax profit of around 15 billion Swiss francs ($14.89 billion) in the next three to five years. The bank said its targets also include a cost-to-income ratio of 65% to 70% and a return on equity of 15% to 20% over the same period. "The transformation we are undertaking is a fundamental one and it will not happen quickly. I am determined, however, that we build a firm for sustainable profit and not one to focus only on short-term expectations," said CEO Oswald Gruebel.
|